江苏和晨药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
4
NMPA:4
Drug Approvals
Ondansetron Oral Soluble Pellicles
- Product Name
- 昂丹司琼口溶膜
- Approval Number
- 国药准字H20253756
- Approval Date
- Apr 1, 2025
NMPA
Ondansetron Oral Soluble Pellicles
- Product Name
- 昂丹司琼口溶膜
- Approval Number
- 国药准字H20253755
- Approval Date
- Apr 1, 2025
NMPA
Abiraterone Acetate Tablets
- Product Name
- 醋酸阿比特龙片
- Approval Number
- 国药准字H20213613
- Approval Date
- Jul 28, 2021
NMPA
Clinical Trials
No trials found
News
No news found